China Chemical and Pharmaceutical Company

China Chemical & Pharmaceutical Co., Ltd. (CCPC) is a Taiwanese pharmaceutical manufacturer with a 70-year history, specializing in generic drugs and APIs. Its core strategy involves developing technologically complex generic products and 505(b)(2) new drug applications for the US market, leveraging development in Asia followed by regulatory partnerships with US-based CMOs and CROs. The company operates as an integrated group, collaborating with sister companies and seeking distribution partnerships overseas to commercialize its niche product portfolio.

Expertise in complex chemistry, manufacturing, and controls (CMC) for small molecules, focusing on high-complexity generic APIs and 505(b)(2) new drug development (new routes of administration, derivatives, or uses). Utilizes a technology transfer model from Asian R&D to US CMOs/CROs.

Competes against large global generic manufacturers (e.g., Teva, Viatris, Sun Pharma) and specialized pharma companies pursuing 505(b)(2) strategies. Differentiation is based on mastering high-complexity manufacturing and efficient Asia-to-US technology development pathways.